Biofourmis Everion+ (G2)
Biofourmis Singapore Pte., Ltd. · Cardiovascular
Open FDA's page for this record- Third party flag
- N
- City
- Singapore
- Advisory committee description
- Cardiovascular
- Address 1
- 2 Venture Dr., Vision Exchange, #23-01
- Statement or summary
- Summary
- Product code
- MSX
- Zip code
- 608526
- Applicant
- Biofourmis Singapore Pte., Ltd.
- Decision date
- 2024-05-09
- Decision code
- SESE
- Country code
- SG
- Device name
- Biofourmis Everion+ (G2)
- Advisory committee
- CV
- Contact
- Seth Kuzdzal
- K number
- K233418
- Date received
- 2023-10-10
- Review advisory committee
- CV
- Postal code
- 608526
- Decision description
- Substantially Equivalent
- Clearance type
- Traditional
- Harmonized identifiers (openFDA)
- Device name
- System, Network And Communication, Physiological Monitors
- Medical specialty description
- Cardiovascular
- Regulation number
- 870.2300
- Device class
- 2
- Registration number
- 3003263092, 3010698831, 3003971136, 3013546957, 3006240053, 3008729547, 1000122786, 3016701404, 3015529350, 3009595635, 3038761440, 3010703925, 2080783, 3015437214, 3011166598, 3016595211, 1824206, 3009499478, 3007603826, 3013783488, 1831750, 3000126629, 9610105, 3016670256, 3009673645, 3016852448, 8020045, 3004906872, 3000976525, 3015134004, 3015173634, 9611500, 3007481893, 3044754336, 9680215, 1651104, 3008058135, 3009973336, 3013596024, 3013500228 +34 more
- FEI number
- 3003263092, 3010698831, 3002806783, 3003971136, 3013546957, 3006240053, 3006254866, 6736, 3008729547, 1000122786, 3001084824, 3016701404, 3015529350, 3009595635, 3038761440, 3010703925, 2080783, 3015437214, 3011166598, 3016595211, 1824206, 3009499478, 3007603826, 3013783488, 1831750, 3000126629, 3016670256, 3002807720, 3009673645, 3016852448, 3004906872, 3000976525, 3002737156, 3015134004, 3015173634, 3001104093, 3044754336, 3008058135, 3002807167, 3009973336 +34 more